S. 1348 · 115th Congress
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
WydenSponsor9 cosponsors · 9 D
D
Cardin
TC
D
Carper
CC
D
Coons
KG
D
Gillibrand
DS
D
Stabenow
JT
D
Tester
TD
D
Duckworth
BM
D
Menendez
HH
D
Heitkamp5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
What it does: CRS summary · Introduced in Senate · Jun 13, 2017
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.
A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
Latest action (Jun 13, 2017): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Jun 13, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.